Studies suggest that it may act as an inhibitor of HCC progression through pathways such as Wnt/β-catenin signaling [34], epithelial-to-mesenchymal transition [35], and the reactive oxygen species (ROS)-HIF-1α signaling cascade [36]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.